K25: Next generation molecular diagnostics for therapy decisions and discovery for all patients with newly diagnosed glioblastoma without MGMT promoter methylation [NCT Neuro Master Match (N2M2) Diagnostics]

HIPO Investigator:

Prof. Dr. Wolfgang Wick

Prof. Dr. Andreas von Deimling

Prof. Dr. Stefan Pfister

Prof. Dr. Christel Herold-Mende

Prof. Dr. Benedikt Brors

Prof. Dr. Jürgen Debus


Supported by: HIPO

Entity: Glioblastoma

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.